Igene Biotechnology, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €3.41M -48.2% -€121.26K -96.5% -3.6% +0.49 pp €64.38K -92.0% 1.9% -0.10 pp
    €6.59M +234.3% -€3.44M +110.2% -52.2% +0.31 pp €802.77K -41.2% 12.2% -0.57 pp
    €1.97M +∞% -€1.64M +64.3% -83.0% -0.83 pp €1.37M +1,585,445.0% 69.3% +0.69 pp
    €0.00 -100.0% -€995.76K -47.4% N/A €86.15 -100.1% N/A
    €399.32K -86.7% -€1.89M -31.1% -474.5% -3.8 pp -€149.58K -85.7% -37.5% -0.027 pp
    €3.01M -16.5% -€2.75M -13.1% -91.4% -0.035 pp -€1.04M -41.4% -34.7% +0.15 pp
    €3.60M +495.1% -€3.16M +62.9% -87.8% +2.3 pp -€1.78M +14.7% -49.5% +2.1 pp
    €605.27K +3,774.8% -€1.94M -10.7% -321.0% +140 pp -€1.55M +9.9% -256.9% +88 pp
    €15.62K -€2.18M -13,928.3% -€1.41M -9,053.6%

    Notifications